A recent paper61, 62 described elevated levels of plasma extracellular vesicle TDP‐43, which is higher in ALS and FTD, and cryptic HDGFL2, a loss‐dependent cryptic epitope, as promising diagnostic biomarkers for ALS. This evidence concerns the gene HDGFL2 and amyotrophic lateral sclerosis.